Inspira Technologies Oxy B H N Ltd's Comment on Sales, Marketing and Customers
The company focuses on providing life support solutions to leading medical centers, group purchasing organizations, and medical device companies, particularly within the perfusionist market. It has established strategic partnerships with medical device companies, manufacturers, and distributors to support global expansion efforts in the U.S., Europe, and Asia. The company markets the INSPIRA ART100 system and related products, which have received FDA 510(k) clearance. Efforts include securing reimbursement and insurance coverage to facilitate adoption by hospitals and medical centers. Collaborations include an exclusive OEM agreement with Terumo Cardiovascular for manufacturing a disposable flow mechanism for the INSPIRA ART systems, and a partnership with Ennocure to develop a bio-electronic treatment aimed at preventing bloodstream infections in ICU patients. The collaboration with Ennocure demonstrated promising in vitro results in reducing bacterial growth, with testing conducted at the Hebrew University of Jerusalem.
News about Inspira Technologies Oxy B H N Ltd Contracts
Revolutionizing Respiratory Care: Inspira Technologies AI-Powered System Set to Transform ICU Treatment for Millions In a groundbreaking development in the healthcare sector, Inspira Technologies (NASDAQ: IINN) is positioned to disrupt the respiratory care market with its innovative, AI-driven respiratory system. The recent PESG Report has detailed the company’s ongoing strategic initiatives and promising clinical achievements, highlighting the significant implications of its technology for the treatment of Intensive Care Unit (ICU) patients. With an estimated 20 million ICU patients annually across the globe, the potential market for Inspira s solutions exceeds $25 billion, indicating a substantial oppor...
In the continuously evolving field of biotechnology, innovation often comes hand in hand with cautious optimism. Inspira Technologies (NASDAQ: IINN) has recently garnered attention for its pioneering advancements in blood monitoring through its AI-powered HYLA blood sensor. The latest update from PESG Research highlights the impressive clinical data released by Inspira Technologies, showcasing a remarkable 96% accuracy in a key parameter when compared to traditional blood analyzers. Breaking New GroundInspira Technologies HYLA blood sensor represents a significant leap forward in the realm of continuous blood monitoring technology. By leveraging artificial intelligence, the device promises not only to enhan...
Inspira Technologies Oxy B H N Ltd’s Comment on Sales, Marketing and Customers
The company focuses on providing life support solutions to leading medical centers, group purchasing organizations, and medical device companies, particularly within the perfusionist market. It has established strategic partnerships with medical device companies, manufacturers, and distributors to support global expansion efforts in the U.S., Europe, and Asia. The company markets the INSPIRA ART100 system and related products, which have received FDA 510(k) clearance. Efforts include securing reimbursement and insurance coverage to facilitate adoption by hospitals and medical centers. Collaborations include an exclusive OEM agreement with Terumo Cardiovascular for manufacturing a disposable flow mechanism for the INSPIRA ART systems, and a partnership with Ennocure to develop a bio-electronic treatment aimed at preventing bloodstream infections in ICU patients. The collaboration with Ennocure demonstrated promising in vitro results in reducing bacterial growth, with testing conducted at the Hebrew University of Jerusalem.
Sources:
Inspira Technologies Oxy B H N Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Inspira Technologies Oxy B H N Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Inspira Technologies Oxy B H N Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
